These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24141275)

  • 61. "Watching time tick by…": Decision making for Duchenne muscular dystrophy trials.
    Peay HL; Scharff H; Tibben A; Wilfond B; Bowie J; Johnson J; Nagaraju K; Escolar D; Piacentino J; Biesecker BB
    Contemp Clin Trials; 2016 Jan; 46():1-6. PubMed ID: 26546066
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evaluation of the quality of life of children with Duchenne's progressive muscular dystrophy].
    Longo-Araujo de Melo E; Moreno-Valdes MT
    Rev Neurol; 2007 Jul 16-31; 45(2):81-7. PubMed ID: 17642047
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool.
    Scott E; Mawson SJ
    Dev Med Child Neurol; 2006 Jun; 48(6):540-4. PubMed ID: 16700951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Parent-child communication and timing of interventions are challenges in the Duchenne muscular dystrophy care.
    Saetrang T; Bjørk IT; Capjon H; Rasmussen M
    Acta Paediatr; 2019 Mar; 108(3):535-540. PubMed ID: 30118557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Social behavior problems in boys with Duchenne muscular dystrophy.
    Hinton VJ; Nereo NE; Fee RJ; Cyrulnik SE
    J Dev Behav Pediatr; 2006 Dec; 27(6):470-6. PubMed ID: 17164619
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patterns of growth in ambulatory males with Duchenne muscular dystrophy.
    West NA; Yang ML; Weitzenkamp DA; Andrews J; Meaney FJ; Oleszek J; Miller LA; Matthews D; DiGuiseppi C
    J Pediatr; 2013 Dec; 163(6):1759-1763.e1. PubMed ID: 24103921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Health-Related Quality of Life in Children with Duchenne Muscular Dystrophy: A Review.
    Wei Y; Speechley K; Campbell C
    J Neuromuscul Dis; 2015 Sep; 2(3):313-324. PubMed ID: 27858736
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Men on the margin: a Bourdieusian examination of living into adulthood with muscular dystrophy.
    Gibson BE; Young NL; Upshur RE; McKeever P
    Soc Sci Med; 2007 Aug; 65(3):505-17. PubMed ID: 17482331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling.
    Peay HL; Hollin IL; Bridges JF
    J Genet Couns; 2016 Apr; 25(2):305-13. PubMed ID: 26289228
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pediatric chronic pain and health-related quality of life.
    Gold JI; Yetwin AK; Mahrer NE; Carson MC; Griffin AT; Palmer SN; Joseph MH
    J Pediatr Nurs; 2009 Apr; 24(2):141-50. PubMed ID: 19268235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benefits of powered standing wheelchair devices for adolescents with Duchenne muscular dystrophy in the first year of use.
    Bayley K; Parkinson S; Jacoby P; Cross D; Morris S; Vorster N; Schofield C; Kava M; Siafarikas A; Evans K; Gaynor O; Chiu L; Ryan MM; Cairns A; Clark D; Downs J
    J Paediatr Child Health; 2020 Sep; 56(9):1419-1425. PubMed ID: 32619315
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mediators affecting family function in families of children with Duchenne muscular dystrophy.
    Chen JY
    Kaohsiung J Med Sci; 2008 Oct; 24(10):514-22. PubMed ID: 19181582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods: The DMD-QoL.
    Powell PA; Carlton J; Rowen D; Chandler F; Guglieri M; Brazier JE
    Neurology; 2021 May; 96(19):e2438-e2450. PubMed ID: 33785551
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [From diagnosis of the disease until today, a father's experience. Interview by Ghislaine Trabacchi].
    Cadiot B
    Soins; 2005 Sep; (698):31. PubMed ID: 16220889
    [No Abstract]   [Full Text] [Related]  

  • 77. Evaluation of an exercise-enabling control interface for powered wheelchair users: a feasibility study with Duchenne muscular dystrophy.
    Lobo-Prat J; Enkaoua A; Rodríguez-Fernández A; Sharifrazi N; Medina-Cantillo J; Font-Llagunes JM; Torras C; Reinkensmeyer DJ
    J Neuroeng Rehabil; 2020 Oct; 17(1):142. PubMed ID: 33115472
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The experiences of patients with Duchenne muscular dystrophy in facing and learning about their clinical conditions.
    Fujino H; Iwata Y; Saito T; Matsumura T; Fujimura H; Imura O
    Int J Qual Stud Health Well-being; 2016; 11():32045. PubMed ID: 27712620
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of food hypersensitivity reported in 9-year-old children by their parents on health-related quality of life.
    Ostblom E; Egmar AC; Gardulf A; Lilja G; Wickman M
    Allergy; 2008 Feb; 63(2):211-8. PubMed ID: 18186811
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
    Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
    Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.